Eyelids oedema as a manifestation of IgG4-related disease: case report and literature review

Aleksandra Adamska, Katarzyna Iskierska

Abstract


IgG4-related disease (IgG4-RD) is a condition of unknown etiology characterized by chronic inflammation leading to fibrosis of the affected organs and impairment of their functions. The variety of clinical manifestations makes its diagnosis a great challenge. This article presents a case study of a patient experiencing skin edema and subcutaneous tissue oedema of the eyelids as a manifestation of IgG4-RD. Treatment with glucocorticosteroids and immunosuppressive agents was administered, which led to a significant reduction in clinical manifestations and an improvement in the patient’s quality of life.

Keywords


IgG4-related disease; IgG4-RD; autoimmune diseases; therapeutic approaches; rheumatology

Full Text:

PDF

References


Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. doi: 10.1136/bmj.m1067.

Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 2019;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603.

Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol 2015;99(3):376-81. doi: 10.1136/bjophthalmol-2014-305545.

Yeşiltaş, YS; Gündüz AK. Idiopathic orbital inflammation: review of literature and new advances. Middle East Afr J Ophthalmol 2018;25(2):71-80. doi: 10.4103/meajo.MEAJO_44_18.

Lai KKH, Aljufairi FMAA, Sebastian JU, Yip CCY, Wei Y, Jia R, et al. Systemic involvement in immunoglobulin G4-related ophthalmic disease. Ocul Immunol Inflamm 2024;32(8):1852-8. doi: 10.1080/09273948.2023.2280709.

Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: Single-center experience and literature review. Semin Arthritis Rheum 2014;43(6):806-17. doi: 10.1016/j.semarthrit.2013.11.008.

Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 2014;71(6):785-93. doi: 10.1001/jamaneurol.2014.243.

Prabhu SM, Yadav V, Irodi A, Mani S, Varghes AM. IgG4-related disease with sinonasal involvement: A case series. Indian J Radiol Imaging 2014;24(2):117-20. doi: 10.4103/0971-3026.134384.

Mulholland GB, Jeffery CC, Satija P, Côté DWJ. Immunoglobulin G4-related diseases in the head and neck: a systematic review. J Otolaryngol Head Neck Surg 2015;44(1):24. doi: 10.1186/s40463-015-0071-9.

Opriţă R, Opriţă B, Berceanu D, Diaconescu IB. Overview of IgG4 – related disease. J Med Life 2017;10(4):203-7.

Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012;2012:580814. doi: 10.1155/2012/580814.

Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907.

Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther 2017;19(1):262. doi: 10.1186/s13075-017-1467-x.

Kasashima S, Kawashima A, Kasashima F, Endo M, Matsumoto Y, Kawakami K. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessels 2018;33(12):1471-81. doi: 10.1007/s00380-018-1203-8.

Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease. Allergy 2014;69(2):269-72.

Martín-Nares E, Hernandez-Molina G. What is the meaning of ANCA positivity in IgG4-related disease? Rheumatology (Oxford) 2021;60(8):3845-50. doi: 10.1093/rheumatology/keab124.

Hara S, Nuka H, Horita S, Zoshima T, Ito K, Aizu M, et al. AB1171 clinical significance of anti-nuclear antibodies in IGG4-related disease. Ann Rheum Dis 2015;74:1294-5.

Peng L, Lu H, Zhou J, Zhang P, Li J, Liu Z, et al. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study. Arthritis Res Ther 2021;23(1):102. doi: 10.1186/s13075-021-02481-3.

Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25(9):1181-92. doi: 10.1038/modpathol.2012.72.

Fujita A, Sakai O, Chapman MN, Sugimoto H. IgG4-related disease of the head and neck: CT and MR imaging manifestations. Radiographics 2012;32(7):1945-58. doi: 10.1148/rg.327125032.

Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol 2011;46(5):696-704. doi: 10.1007/s00535-010-0361-y.

Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015;67(7):1688-99. doi: 10.1002/art39132.




DOI: https://doi.org/10.21164/pomjlifesci.1075

Copyright (c) 2025 Aleksandra Adamska, Katarzyna Iskierska

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/